161 related articles for article (PubMed ID: 35188805)
1. Clinical Validity of Plasma-Based Genotyping for Microsatellite Instability Assessment in Advanced GI Cancers: SCRUM-Japan GOZILA Substudy.
Nakamura Y; Okamoto W; Denda T; Nishina T; Komatsu Y; Yuki S; Yasui H; Esaki T; Sunakawa Y; Ueno M; Shinozaki E; Matsuhashi N; Ohta T; Kato K; Ohtsubo K; Bando H; Hara H; Satoh T; Yamazaki K; Yamamoto Y; Okano N; Terazawa T; Kato T; Oki E; Tsuji A; Horita Y; Hamamoto Y; Kawazoe A; Nakajima H; Nomura S; Mitani R; Yuasa M; Akagi K; Yoshino T
JCO Precis Oncol; 2022 Feb; 6():e2100383. PubMed ID: 35188805
[TBL] [Abstract][Full Text] [Related]
2. Clinical Validation of Plasma-Based Genotyping for
Aoki Y; Nakamura Y; Denda T; Ohta T; Esaki T; Shiozawa M; Yamaguchi K; Yamazaki K; Sunakawa Y; Kato T; Okano N; Taniguchi H; Sato T; Oki E; Nishina T; Komatsu Y; Matsuhashi N; Goto M; Yasui H; Ohtsubo K; Moriwaki T; Takahashi N; Horita Y; Boku S; Wakabayashi M; Ikeno T; Mitani R; Yuasa M; Yoshino T
JCO Precis Oncol; 2023 Jun; 7():e2200688. PubMed ID: 37343204
[TBL] [Abstract][Full Text] [Related]
3. Clinical utility of circulating tumor DNA sequencing in advanced gastrointestinal cancer: SCRUM-Japan GI-SCREEN and GOZILA studies.
Nakamura Y; Taniguchi H; Ikeda M; Bando H; Kato K; Morizane C; Esaki T; Komatsu Y; Kawamoto Y; Takahashi N; Ueno M; Kagawa Y; Nishina T; Kato T; Yamamoto Y; Furuse J; Denda T; Kawakami H; Oki E; Nakajima T; Nishida N; Yamaguchi K; Yasui H; Goto M; Matsuhashi N; Ohtsubo K; Yamazaki K; Tsuji A; Okamoto W; Tsuchihara K; Yamanaka T; Miki I; Sakamoto Y; Ichiki H; Hata M; Yamashita R; Ohtsu A; Odegaard JI; Yoshino T
Nat Med; 2020 Dec; 26(12):1859-1864. PubMed ID: 33020649
[TBL] [Abstract][Full Text] [Related]
4. Pan-Cancer Prevalence of Microsatellite Instability-High (MSI-H) Identified by Circulating Tumor DNA and Associated Real-World Clinical Outcomes.
Kasi PM; Bucheit LA; Liao J; Starr J; Barata P; Klempner SJ; Gandara D; Shergill A; Madeira da Silva L; Weipert C; Zhang N; Pretz C; Hardin A; Kiedrowski LA; Odegaard JI
JCO Precis Oncol; 2023 Sep; 7():e2300118. PubMed ID: 37769226
[TBL] [Abstract][Full Text] [Related]
5. Validation of Microsatellite Instability Detection Using a Comprehensive Plasma-Based Genotyping Panel.
Willis J; Lefterova MI; Artyomenko A; Kasi PM; Nakamura Y; Mody K; Catenacci DVT; Fakih M; Barbacioru C; Zhao J; Sikora M; Fairclough SR; Lee H; Kim KM; Kim ST; Kim J; Gavino D; Benavides M; Peled N; Nguyen T; Cusnir M; Eskander RN; Azzi G; Yoshino T; Banks KC; Raymond VM; Lanman RB; Chudova DI; Talasaz A; Kopetz S; Lee J; Odegaard JI
Clin Cancer Res; 2019 Dec; 25(23):7035-7045. PubMed ID: 31383735
[TBL] [Abstract][Full Text] [Related]
6. Validation of a Circulating Tumor DNA-Based Next-Generation Sequencing Assay in a Cohort of Patients with Solid tumors: A Proposed Solution for Decentralized Plasma Testing.
Al Zoughbi W; Fox J; Beg S; Papp E; Hissong E; Ohara K; Keefer L; Sigouros M; Kane T; Bockelman D; Nichol D; Patchell E; Bareja R; Karandikar A; Alnajar H; Cerqueira G; Guthrie VB; Verner E; Manohar J; Greco N; Wilkes D; Tagawa S; Malbari MS; Holcomb K; Eng KW; Shah M; Altorki NK; Sboner A; Nanus D; Faltas B; Sternberg CN; Simmons J; Houvras Y; Molina AM; Angiuoli S; Elemento O; Mosquera JM
Oncologist; 2021 Nov; 26(11):e1971-e1981. PubMed ID: 34286887
[TBL] [Abstract][Full Text] [Related]
7. Detection of Microsatellite Instability from Circulating Tumor DNA by Targeted Deep Sequencing.
Cai Z; Wang Z; Liu C; Shi D; Li D; Zheng M; Han-Zhang H; Lizaso A; Xiang J; Lv J; Wu W; Zhang Z; Zhang Z; Yuan F; He S; Sun J
J Mol Diagn; 2020 Jul; 22(7):860-870. PubMed ID: 32428677
[TBL] [Abstract][Full Text] [Related]
8. Clinical activity of pembrolizumab in metastatic prostate cancer with microsatellite instability high (MSI-H) detected by circulating tumor DNA.
Barata P; Agarwal N; Nussenzveig R; Gerendash B; Jaeger E; Hatton W; Ledet E; Lewis B; Layton J; Babiker H; Bryce A; Garje R; Stein C; Kiedrowski L; Saylor P; Sartor O
J Immunother Cancer; 2020 Aug; 8(2):. PubMed ID: 32788235
[TBL] [Abstract][Full Text] [Related]
9. Detection of microsatellite instability-high (MSI-H) by liquid biopsy predicts robust and durable response to immunotherapy in patients with pancreatic cancer.
Chakrabarti S; Bucheit L; Starr JS; Innis-Shelton R; Shergill A; Dada H; Resta R; Wagner S; Fei N; Kasi PM
J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35710297
[TBL] [Abstract][Full Text] [Related]
10. Effects of Metastatic Sites on Circulating Tumor DNA in Patients With Metastatic Colorectal Cancer.
Bando H; Nakamura Y; Taniguchi H; Shiozawa M; Yasui H; Esaki T; Kagawa Y; Denda T; Satoh T; Yamazaki K; Sunakawa Y; Kato T; Goto M; Yuki S; Nishina T; Oki E; Shinozaki E; Matsuhashi N; Takahashi N; Tsuji A; Ohtsubo K; Wakabayashi M; Ikeno T; Hata M; Odegaard JI; Yoshino T
JCO Precis Oncol; 2022 Apr; 6():e2100535. PubMed ID: 35544728
[TBL] [Abstract][Full Text] [Related]
11. Molecular characterization of ctDNA from Chinese patients with advanced gastric adenocarcinoma reveals actionable alterations for targeted and immune therapy.
Zhang M; Qi C; Wang Z; Chen H; Zhao X; Zhang X; Zhou Y; Gao C; Bai Y; Jia S; Ji J
J Mol Med (Berl); 2021 Sep; 99(9):1311-1321. PubMed ID: 34057552
[TBL] [Abstract][Full Text] [Related]
12. A next-generation sequencing-based strategy combining microsatellite instability and tumor mutation burden for comprehensive molecular diagnosis of advanced colorectal cancer.
Xiao J; Li W; Huang Y; Huang M; Li S; Zhai X; Zhao J; Gao C; Xie W; Qin H; Cai S; Bai Y; Lan P; Zou Y
BMC Cancer; 2021 Mar; 21(1):282. PubMed ID: 33726687
[TBL] [Abstract][Full Text] [Related]
13. Plasma-based microsatellite instability detection strategy to guide immune checkpoint blockade treatment.
Wang Z; Zhao X; Gao C; Gong J; Wang X; Gao J; Li Z; Wang J; Yang B; Wang L; Zhang B; Zhou Y; Wang D; Li X; Bai Y; Li J; Shen L
J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33172882
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of Targeted Trials and Signaling Pathway Landscape in Advanced Gastrointestinal Cancers From SCRUM-Japan GI-SCREEN: A Nationwide Genomic Profiling Program.
Nakamura Y; Yamashita R; Okamoto W; Komatsu Y; Yuki S; Ueno M; Kato K; Taniguchi H; Kagawa Y; Denda T; Hara H; Esaki T; Moriwaki T; Sunakawa Y; Oki E; Nagashima F; Nishina T; Satoh T; Kawakami H; Yamaguchi K; Ohtsubo K; Kato T; Horita Y; Tsuji A; Yasui H; Goto M; Hamamoto Y; Wakabayashi M; Ikeno T; Shitara K; Bando H; Tsuchihara K; Miki I; Ichiki H; Ohtsu A; Yoshino T
JCO Precis Oncol; 2023 Mar; 7():e2200653. PubMed ID: 36996376
[TBL] [Abstract][Full Text] [Related]
15. Analytical validation and clinical utilization of K-4CARE™: a comprehensive genomic profiling assay with personalized MRD detection.
Nguyen Hoang TP; Nguyen TA; Tran NHB; Nguyen Hoang VA; Thi Dao HT; Tran VU; Nguyen YN; Nguyen AT; Nguyen Thi CT; Do Thi TT; Nguyen DS; Nguyen HN; Giang H; Tu LN
Front Mol Biosci; 2024; 11():1334808. PubMed ID: 38404964
[No Abstract] [Full Text] [Related]
16. Clinical responses to PD-1 inhibition and their molecular characterization in six patients with mismatch repair-deficient metastatic cancer of the digestive system.
Hirsch D; Gaiser T; Merx K; Weingaertner S; Forster M; Hendricks A; Woenckhaus M; Schubert T; Hofheinz RD; Gencer D
J Cancer Res Clin Oncol; 2021 Jan; 147(1):263-273. PubMed ID: 32776177
[TBL] [Abstract][Full Text] [Related]
17. Microsatellite instability in Japanese female patients with triple-negative breast cancer.
Kurata K; Kubo M; Kai M; Mori H; Kawaji H; Kaneshiro K; Yamada M; Nishimura R; Osako T; Arima N; Okido M; Oda Y; Nakamura M
Breast Cancer; 2020 May; 27(3):490-498. PubMed ID: 31907878
[TBL] [Abstract][Full Text] [Related]
18. Clinical impact of microsatellite instability in colon cancer following adjuvant FOLFOX therapy.
Kim ST; Lee J; Park SH; Park JO; Lim HY; Kang WK; Kim JY; Kim YH; Chang DK; Rhee PL; Kim DS; Yun H; Cho YB; Kim HC; Yun SH; Lee WY; Chun HK; Park YS
Cancer Chemother Pharmacol; 2010 Sep; 66(4):659-67. PubMed ID: 20033812
[TBL] [Abstract][Full Text] [Related]
19. Concordance analysis of microsatellite instability status between polymerase chain reaction based testing and next generation sequencing for solid tumors.
Shimozaki K; Hayashi H; Tanishima S; Horie S; Chida A; Tsugaru K; Togasaki K; Kawasaki K; Aimono E; Hirata K; Nishihara H; Kanai T; Hamamoto Y
Sci Rep; 2021 Oct; 11(1):20003. PubMed ID: 34625576
[TBL] [Abstract][Full Text] [Related]
20. High concordance of actionable genomic alterations identified between circulating tumor DNA-based and tissue-based next-generation sequencing testing in advanced non-small cell lung cancer: The Korean Lung Liquid Versus Invasive Biopsy Program.
Park S; Olsen S; Ku BM; Lee MS; Jung HA; Sun JM; Lee SH; Ahn JS; Park K; Choi YL; Ahn MJ
Cancer; 2021 Aug; 127(16):3019-3028. PubMed ID: 33826761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
